As you might know, Pfizer Inc. (NYSE:PFE) recently reported its second-quarter numbers. It was not a great result…

As you might know, Pfizer Inc. (NYSE:PFE) recently reported its second-quarter numbers. It was not a great result…

(Bloomberg) — Wall Street analysts and specialists are weighing the possibility that Pfizer Inc. and BioNTech SE may file their Covid-19 vaccine candidate with regulators by October after the pair said a late-stage Covid-19 vaccine study kicked off on Monday evening.Pfizer rose Tuesday on the announcement with its German partner, just hours after similar ne […]

The U.S. government has reached a $1.95 billion deal with Pfizer and BioNTech for 100 million doses of their experimental COVID-19 vaccine after it receives regulatory approval from the Food and Drug Administration.
